#1705024 A Randomized Phase 3 Trial to Assess Efficacy and Safety of a Novel Formulation of Octreotide Subcutaneous Depot (CAM2029) in Patients With Acromegaly

Autor: Silverstein, Julie, Ferone, Diego, Freda, Pamela, Katznelson, Laurence, Gatto, Federico, Kadioglu, Pinar, Maffei, Pietro, Seufert, Jochen, Spencer-Segal, Joanna L., Isaeva, Elena, Dreval, Alexander, Harrie, Maria, Svedberg, Agneta, Tiberg, Fredrik
Zdroj: In Endocrine Practice May 2024 30(5) Supplement:S117-S118
Databáze: ScienceDirect